Intron Biotechnology Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

1999

Location

Seongnam Gyeonggi-do South Korea

Primary Industry

Biotechnology

About

Established in 1999 and based in Seongnam-si, South Korea, Intron Biotechnology Co., Ltd. operates as a biotechnology company that focuses on R&D in antibacterial drugs targeting MRSA as well as other antibiotic resistant bacteria.

Current Investors

IMM Private Equity

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.intron.co.kr

Verticals

HealthTech, Manufacturing

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2011

8,553,229,745

295,616,032

3.5%

1,044,238,091

12.2%

323,771,195

3.8%

31 Dec 2012

8,174,343,856

(4.4%)

(1,115,163,149)

(13.6%)

(110,633,601)

(1.4%)

(1,184,208,402)

(14.5%)

31 Dec 2013

9,276,560,731

13.5%

58,869,729

0.6%

1,094,346,053

11.8%

353,675,425

3.8%

31 Dec 2014

9,980,378,070

7.6%

1,125,090,411

11.3%

1,936,325,100

19.4%

20,530,801

0.2%

31 Dec 2015

11,835,199,687

18.6%

2,131,855,140

18%

3,103,820,547

26.2%

1,557,912,185

13.2%

31 Dec 2016

10,222,261,221

(13.6%)

(1,200,391,881)

(11.7%)

52,630,145

0.5%

(610,377,168)

(6%)

31 Dec 2017

10,962,773,686

7.2%

(3,900,277,096)

(35.6%)

(3,004,212,018)

(27.4%)

(8,734,807,381)

(79.7%)

31 Dec 2018

20,584,390,702

87.8%

5,165,702,034

25.1%

6,106,144,642

29.7%

8,708,964,811

42.3%

31 Dec 2019

8,347,462,254

(59.4%)

(4,368,077,903)

(52.3%)

(2,944,516,403)

(35.3%)

(3,187,562,179)

(38.2%)

31 Dec 2020

45,433,157,199

444.3%

15,736,219,290

34.6%

17,305,340,567

38.1%

14,947,967,156

32.9%

31 Dec 2021

31 Dec 2022

31 Dec 2023

Unlock the recent years of financials and more for Intron Biotechnology Co., Ltd..

Request a demo to see more.

Deals

Deals Type
PIPE

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Intron Biotechnology Co., Ltd.	02 Feb 2016

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.